适应性抑制MAPT转录 维持人体神经元发育中的陶蛋白质稳定
Mallory R Shin1, Narges Firouzshahi1, Gage Liddiard1
1University of Iowa.
Research square
|November 19, 2025
概括
当蛋白质清除失败时,神经元激活质量控制并减少tau的产生. 这种蛋白质稳定第一反应涉及对MAPT和神经元需求的转录抑制,为阿尔茨海默病等陶病症提供了目标.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 发育中的神经元可以容忍高水平,这表明对蛋白质聚合的保护机制.
- 蛋白质清除受损可以导致神经毒性,特别是在阿尔茨海默氏症等病中.
研究的目的:
- 研究人类神经元中对蛋白酶体抑制的细胞反应.
- 在蛋白质静止应激期间识别抑制tau (MAPT) 表达的机制.
- 为了发现细胞应激期间调节MAPT的转录因子.
主要方法:
- 诱导多能干细胞 (iPSC) 衍生的人类前脑神经元被治疗以epoxomicin阻止蛋白质酶体.
- 用RNA测序 (RNA-seq) 和定量PCR (qPCR) 来分析基因表达变化.
- 进行了人类皮质组织的共聚焦成像和生物信息分析 (HOMER,ChEA3,JASPAR).
主要成果:
- 蛋白质酶阻断诱导了一个协调的转录基因程序,对蛋白质稳定路径进行上调和对与MAPT相关的神经元功能进行下调.
- 在蛋白质酶损伤时,MAPT转录物减少,而蛋白水平也减少.
- 的过度表达绕过了转录抑制,导致在蛋白质酶抑制过程中的增加.
- 人类皮质成像显示tau与蛋白酶体和溶酶体标记物的同位化.
- 生物信息分析确定了E2F1,EVT1,Lhx1和TCF3作为MAPT的潜在调节者.
结论:
- 神经元采用"蛋白质稳定第一"适应来管理蛋白质酶功能障碍期间的tau负担.
- 这涉及激活质量控制机制和转录性下调MAPT和相关的神经元需求.
- 已识别的转录因子为调节阿尔茨海默病和相关的陶病的陶稳定提供了潜在的治疗点.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.自自是自的过程.诱导多能干细胞 (iPS细胞) (iPSC) 是一种神经退行症的神经退行症神经发育的神经发育神经元神经元的神经元神经保护性神经保护剂蛋白质稳定症是一种蛋白质稳定症.蛋白 (tau) 是一种蛋白.病症是一种病症.乌比奎丁-蛋白酶体系统更多相关视频
12:55Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
9.4K
10:38Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
Published on: December 22, 2023
1000
相关概念视频
Microtubule Associated Proteins (MAPs)
5.7K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
5.7K
Microtubule Instability
6.0K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
6.0K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
